Epstein-Barr virus DNA quantification and follow-up in Tunisian nasopharyngeal carcinoma patients

Elham Hassen, Karim Farhat, Sallouha Gabbouj, Noureddine Bouaouina, Hamdi Abdelaziz, Lotfi Chouchane

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The prognostic value of the Epstein-Barr virus (EBV) DNA load in sera of nasopharyngeal carcinoma (NPC) patients measured before any treatment, after treatment and before relapse was assessed. The real-time polymerase chain reaction was used to detect the viral load levels among 74 NPC subjects. Patients were followed up for a period going from 1 to 6 years (median 4 years). Before treatment, the EBV DNA load was correlated with lymph node involvement and advanced stages. After treatment, the viral load level declined significantly and patients presenting a viral load level lower than 1000 copies/ml showed a better overall survival (OS). Moreover, a significant result was found when the 6-year OS rates of patients having fewer or more than 15,000 copies/ml of viral load before relapse were compared. These results suggest that the EBV DNA load quantification after treatment may be a useful predictor of disease progression and survival.

Original languageEnglish
Pages (from-to)274-280
Number of pages7
JournalBiomarkers
Volume16
Issue number3
DOIs
Publication statusPublished - May 2011

Fingerprint

Human Herpesvirus 4
Viruses
Viral Load
DNA
Polymerase chain reaction
Therapeutics
Recurrence
Survival
Disease Progression
Real-Time Polymerase Chain Reaction
Survival Rate
Lymph Nodes
Nasopharyngeal carcinoma
Serum

Keywords

  • EBV DNA load
  • NPC
  • prognosis
  • survivals

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis

Cite this

Epstein-Barr virus DNA quantification and follow-up in Tunisian nasopharyngeal carcinoma patients. / Hassen, Elham; Farhat, Karim; Gabbouj, Sallouha; Bouaouina, Noureddine; Abdelaziz, Hamdi; Chouchane, Lotfi.

In: Biomarkers, Vol. 16, No. 3, 05.2011, p. 274-280.

Research output: Contribution to journalArticle

Hassen, Elham ; Farhat, Karim ; Gabbouj, Sallouha ; Bouaouina, Noureddine ; Abdelaziz, Hamdi ; Chouchane, Lotfi. / Epstein-Barr virus DNA quantification and follow-up in Tunisian nasopharyngeal carcinoma patients. In: Biomarkers. 2011 ; Vol. 16, No. 3. pp. 274-280.
@article{beddad4cfacb424c94637290c6618699,
title = "Epstein-Barr virus DNA quantification and follow-up in Tunisian nasopharyngeal carcinoma patients",
abstract = "The prognostic value of the Epstein-Barr virus (EBV) DNA load in sera of nasopharyngeal carcinoma (NPC) patients measured before any treatment, after treatment and before relapse was assessed. The real-time polymerase chain reaction was used to detect the viral load levels among 74 NPC subjects. Patients were followed up for a period going from 1 to 6 years (median 4 years). Before treatment, the EBV DNA load was correlated with lymph node involvement and advanced stages. After treatment, the viral load level declined significantly and patients presenting a viral load level lower than 1000 copies/ml showed a better overall survival (OS). Moreover, a significant result was found when the 6-year OS rates of patients having fewer or more than 15,000 copies/ml of viral load before relapse were compared. These results suggest that the EBV DNA load quantification after treatment may be a useful predictor of disease progression and survival.",
keywords = "EBV DNA load, NPC, prognosis, survivals",
author = "Elham Hassen and Karim Farhat and Sallouha Gabbouj and Noureddine Bouaouina and Hamdi Abdelaziz and Lotfi Chouchane",
year = "2011",
month = "5",
doi = "10.3109/1354750X.2010.551409",
language = "English",
volume = "16",
pages = "274--280",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Epstein-Barr virus DNA quantification and follow-up in Tunisian nasopharyngeal carcinoma patients

AU - Hassen, Elham

AU - Farhat, Karim

AU - Gabbouj, Sallouha

AU - Bouaouina, Noureddine

AU - Abdelaziz, Hamdi

AU - Chouchane, Lotfi

PY - 2011/5

Y1 - 2011/5

N2 - The prognostic value of the Epstein-Barr virus (EBV) DNA load in sera of nasopharyngeal carcinoma (NPC) patients measured before any treatment, after treatment and before relapse was assessed. The real-time polymerase chain reaction was used to detect the viral load levels among 74 NPC subjects. Patients were followed up for a period going from 1 to 6 years (median 4 years). Before treatment, the EBV DNA load was correlated with lymph node involvement and advanced stages. After treatment, the viral load level declined significantly and patients presenting a viral load level lower than 1000 copies/ml showed a better overall survival (OS). Moreover, a significant result was found when the 6-year OS rates of patients having fewer or more than 15,000 copies/ml of viral load before relapse were compared. These results suggest that the EBV DNA load quantification after treatment may be a useful predictor of disease progression and survival.

AB - The prognostic value of the Epstein-Barr virus (EBV) DNA load in sera of nasopharyngeal carcinoma (NPC) patients measured before any treatment, after treatment and before relapse was assessed. The real-time polymerase chain reaction was used to detect the viral load levels among 74 NPC subjects. Patients were followed up for a period going from 1 to 6 years (median 4 years). Before treatment, the EBV DNA load was correlated with lymph node involvement and advanced stages. After treatment, the viral load level declined significantly and patients presenting a viral load level lower than 1000 copies/ml showed a better overall survival (OS). Moreover, a significant result was found when the 6-year OS rates of patients having fewer or more than 15,000 copies/ml of viral load before relapse were compared. These results suggest that the EBV DNA load quantification after treatment may be a useful predictor of disease progression and survival.

KW - EBV DNA load

KW - NPC

KW - prognosis

KW - survivals

UR - http://www.scopus.com/inward/record.url?scp=79955117387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955117387&partnerID=8YFLogxK

U2 - 10.3109/1354750X.2010.551409

DO - 10.3109/1354750X.2010.551409

M3 - Article

VL - 16

SP - 274

EP - 280

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 3

ER -